3.4. Proportion of CD3+CD4+, CD3+CD8+, CD3−CD19+, and CD16+CD56+ Cells and Associated Cytokines Concentration in Peripheral Blood of Patients with Multiple Myeloma. This evidence concerns the gene CD8A and plasma cell myeloma.